ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 256 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,338,827,000 | -59.3% | 32,331 | -41.4% | 0.02% | -53.5% |
| Q2 2022 | $3,292,039,000 | -8.2% | 55,180 | +11.7% | 0.04% | +4.9% |
| Q1 2022 | $3,585,975,000 | -16.0% | 49,380 | -2.8% | 0.04% | -6.8% |
| Q4 2021 | $4,270,090,000 | -10.8% | 50,780 | -4.3% | 0.04% | -13.7% |
| Q3 2021 | $4,787,286,000 | +3.6% | 53,080 | +9.5% | 0.05% | +10.9% |
| Q2 2021 | $4,622,758,000 | -19.7% | 48,482 | -4.1% | 0.05% | -28.1% |
| Q1 2021 | $5,758,014,000 | -4.3% | 50,571 | +16.3% | 0.06% | -5.9% |
| Q4 2020 | $6,017,690,000 | +87.8% | 43,471 | +11.5% | 0.07% | +58.1% |
| Q3 2020 | $3,204,341,000 | +16.8% | 38,987 | +11.1% | 0.04% | +4.9% |
| Q2 2020 | $2,744,505,000 | – | 35,087 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |